DRD2 and glioblastoma: In glioblastoma (GBM), tumor cells autonomously synthesize dopamine, activating dopamine receptor D2 and significantly increasing glucose uptake and glycolytic flux, establishing a unique, dopamine-driven metabolic program [88].